Meta-Analysis of Trials Comparing Gemcitabine and Pegylated Liposomal Doxorubicin for Treatment in Women with Progressive or Recurrent Ovarian Cancer

Meta-Analysis of Trials Comparing Gemcitabine and Pegylated Liposomal Doxorubicin for Treatment in Women with Progressive or Recurrent Ovarian Cancer

OBJECTIVE To evaluate the efficacy and adverse effects of gemcitabine versus pegylated liposomal doxorubicin in patients with progressive or recurrent ovarian cancer. METHODS We conducted a systematic literature search to identify all randomized controlled trials comparing gemcitabine and pegy...

Full description

Bibliographic Details
Main Authors: Xia LIU, Li MA, Jinhui TIAN
Format: Article
Language:English
Published: China Anti-Cancer Association 2009-12-01
Series:Cancer Biology & Medicine
Subjects:
gemcitabine
pegylated liposomal doxorubicin
ovarian cancer
meta-analysis.
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/247

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/247

Similar Items